ArticleFrontiers in oncology2019

Phase 2 Multicenter Study of Gantry-Based Stereotactic Radiotherapy Boost for Intermediate and High Risk Prostate Cancer (PROMETHEUS).

David Pryor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.